NIH study showed higher mortality rates for patients on respiratory support in rural intermediate care units
On Jan. 31, 2024, a National Institutes of Health-supported study found that patients receiving ventilator life support in…
Neuralink implanted brain chip in first human subject
On Jan. 29, 2024, Neuralink announced that the first human patient had received an implant from brain-chip and…
Agriculture | Disease | Influenza | Life Science News | WHO
Avian influenza A(H10N5) and influenza A(H3N2) coinfection reported in China
On Jan. 27, 2024, the National Health Commission of the People’s Republic of China notified the World Health…
Washington University’s Jeffrey T. Fort Neuroscience Research building dedicated
On Jan. 25, 2024, dozens of noted scientists, philanthropists, and Washington University, state and local leaders celebrated the…
HPV vaccine study found zero cases of cervical cancer among women vaccinated before age 14
On Jan. 25, 2024, an historic study out of Scotland showed the real-world impact of vaccines against the…
Biotechnology | Diagnostics | Disease | Life Science News | Medical Device | Non-Profit Research | Therapeutics
Small robot made big difference for cochlear implant patient at Oregon Health & Science University
On Jan. 24, 2024, Oregon Health & Science University announced that Pamela Runner, 77, of Corvallis, became the…
Catastrophic mortality of elephant seals in Argentina Identified as outbreak of avian influenza
On Jan. 22, 2024, the University of California, Davis announced the first reported outbreak of high pathogenicity H5N1…
Biotechnology | CRISPR | Disease | FDA | Life Science News | Therapeutics
CRISPR Therapeutics announced FDA approval of CASGEVY for treatment of ransfusion-dependent beta thalassemia
On Jan. 16, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved CRISPR Therapeutics’ CASGEVY…
Swissmedic Authorises CSL’s HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia B
On Jan. 15, 2024, CSL announced that Swissmedic had authorised HEMGENIX® (etranacogene dezaparvovec), the first and currently only gene…
WHO certified Cabo Verde as malaria-free, marking a historic milestone in the fight against malaria
On Jan. 12, 2024, the World Health Organization (WHO) announced it had certified Cabo Verde as a malaria-free…
NIH-supported researchers created single-cell atlas of the placenta during term labor
On Jan. 10, 2024, an National Institutes of Health (NIH) supported study announced an n atlas revealing the…
First polar bear died of avian flu
On Jan. 9, 2024, biologists in Alaska have confirmed the first case of a polar bear dying after…
Health effects associated with exposure to secondhand smoke: a Burden of Proof study
On Jan. 9, 2024, the Institute for Health Metrics and Evaluation (HHMI) reported that despite a gradual decline…
‘LEQEMBI’ (Lecanemab) approved for treatment of Alzheimer’s disease in China
On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…
FDA authorized Florida’s Drug Importation Program
On Jan. 5, 2024, the U.S. Food and Drug Administration (FDA) authorized Florida’s Agency for Health Care Administration’s…
France detected bird flu on vaccinated ducks farm
On Jan. 4, 2024, France announced it had detected bird flu on a duck farm in the Vendee…
Beyfortus approved in China for the prevention of RSV disease in infants
On Jan. 4, 2024, AstraZeneca Sanofiﾒs Beyfortus (nirsevimab), a long-acting monoclonal antibody, was approved in China for the…